Ind-Swift Ltd.
| BSE: 524652 | Sector: Health care |
| NSE: INDSWFTLTD | ISIN Code: INE788B01028 |
| BSE 00:00 | 24 Apr | Ind-Swift Ltd |
| NSE 05:30 | 01 Jan | Ind-Swift Ltd |
| OPEN | 2.75 |
| PREVIOUS CLOSE | 2.85 |
| VOLUME | 300 |
| 52-Week high | 5.94 |
| 52-Week low | 2.05 |
| P/E | |
| Mkt Cap.(Rs cr) | 15 |
| Buy Price | 2.85 |
| Buy Qty | 513.00 |
| Sell Price | 2.75 |
| Sell Qty | 830.00 |
Ind-Swift Ltd. (INDSWFTLTD) - Company Information
Ind-Swift Ltd
Ind-Swift Ltd is an India-based pharmaceutical company. The company is engaged in the manufacturing and marketing of pharmaceutical finished dosage. The products manufactured by the company include cephalosporins, quinolones, aminoglycosides, macrolides, chloramphenicol, tetracyclines, sulphonamides, antianaerobics and anti-fungals. The company manufactures various dosage forms, including oral...> More
| COMPANY INFORMATION | |||||||
| Managing Director & CEO : | G Munjal | ||||||
| Chairman : | S R Mehta | ||||||
| Joint Managing Director : | V R Mehta | ||||||
| Director : | Himanshu Jain | ||||||
| Vice Chairman : | N R Munjal | ||||||
| Director : | Rishav Mehta | ||||||
| Independent Director : | S P Sharma | ||||||
| Independent Director : | V K Arora | ||||||
| Nominee (PNB) : | B M Pahda | ||||||
| Independent Director : | Subhash Chander Galhotra | ||||||
| Independent Director : | Anoop Michra | ||||||
| Independent Director : | Jagvir Singh Ahluwalia | ||||||
| Independent Director : | J K Kakkar | ||||||
| Company Secretary : | Amrender Kumar Yadav | ||||||
| AUDITOR : | Jain & Associates | ||||||
| IND NAME : | Pharmaceuticals - Indian - Formulations | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| 781 Industrial Area Phase-II, Ram Darbar,Chandigarh,Chandigarh-160002 | |||||||
| Ph : 91-0172-2638781-786 | |||||||
| WEBSITE : http://www.indswift.com | |||||||
| E-mail : corporate@indswift.com | |||||||
Quick Links for Ind-Swift:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
